PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis
Abstract:
Deregulation of mitogen-activated protein kinase (MAPK) signaling leads to development of pancreatic cancer. Although Ras-mutation-driven pancreatic tumorigenesis is well understood, the underlying mechanism of Ras-independent MAPK hyperactivation remains elusive. Here, we have identified a distinct function of PCNA-associated factor (PAF) in modulating MAPK signaling. PAF is overexpressed in pancreatic cancer and required for pancreatic cancer cell proliferation. In mouse models, PAF expression induced pancreatic intraepithelial neoplasia with expression of pancreatic cancer stem cell markers. PAF-induced ductal epithelial cell hyperproliferation was accompanied by extracellular signal-regulated kinase (ERK) phosphorylation independently of Ras or Raf mutations. Intriguingly, PAF transcriptionally activated the expression of late endosomal/lysosomal adaptor, MAPK and mTOR activator 3 (LAMTOR3), which hyperphosphorylates MEK and ERK and is necessary for pancreatic cancer cell proliferation. Our results reveal an unsuspected mechanism of mitogenic signaling activation via LAMTOR3 and suggest that PAF-induced MAPK hyperactivation contributes to pancreatic tumorigenesis.
Insights
PCNA-associated factor (PAF) drives pancreatic cancer by activating MAPK signaling independently of Ras mutations. PAF overexpression leads to LAMTOR3 activation, promoting cell proliferation and tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Mitogen-activated protein kinase (MAPK) signaling pathway dysregulation is a key driver in pancreatic cancer development.
- While Ras-mutation-driven pancreatic cancer is understood, the mechanisms behind Ras-independent MAPK hyperactivation are unclear.
Purpose of the Study:
- To investigate the role of PCNA-associated factor (PAF) in pancreatic cancer pathogenesis.
- To elucidate the mechanism by which PAF contributes to Ras-independent MAPK hyperactivation and pancreatic tumorigenesis.
Main Methods:
- Analysis of PAF expression in pancreatic cancer tissues and cell lines.
- Utilized mouse models to study the effects of PAF expression on pancreatic intraepithelial neoplasia and cancer stem cell markers.
- Investigated the impact of PAF on extracellular signal-regulated kinase (ERK) phosphorylation and its dependence on Ras/Raf mutations.
- Examined the transcriptional regulation of LAMTOR3 by PAF and its role in MAPK/mTOR signaling.
Main Results:
- PAF is overexpressed in pancreatic cancer and essential for cancer cell proliferation.
- PAF expression in mouse models induced pancreatic intraepithelial neoplasia and cancer stem cell markers.
- PAF-induced ductal epithelial cell hyperproliferation and ERK phosphorylation occurred independently of Ras or Raf mutations.
- PAF transcriptionally activates LAMTOR3, leading to MEK and ERK hyperphosphorylation, crucial for pancreatic cancer cell proliferation.
Conclusions:
- PAF plays a significant role in pancreatic tumorigenesis through a novel mechanism involving LAMTOR3.
- PAF-induced MAPK hyperactivation, mediated by LAMTOR3, represents a potential therapeutic target for pancreatic cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation


